0

Bicalutamide (CDX)

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP90357065-A
CAS90357-06-5
Structure
MDL NumberMFCD00869971
Molecular Weight430.37
InChI KeyLKJPYSCBVHEWIU-UHFFFAOYSA-N
Description≥98% (HPLC), powder
SolubilityDMSO: >5 mg/mL; H2O: insoluble
Assay≥98% (HPLC)
Formpowder; protect from light
Size10MG, 50MG
1

CACUL1 Functions as a Negative Regulator of Androgen Receptor in Prostate Cancer Cells

Hanbyeul Choi, Sang Hyup Lee, Soo-Jong Um, Eun-Joo Kim

Cancer Lett. 2016 Jul 1;376(2):360-6.

PMID: 27085459

1

Cell-cycle Regulators cdk2ap1 and Bicalutamide Suppress Malignant Biological Interactions Between Prostate Cancer and Bone Cells

Olga Zolochevska, Marxa L Figueiredo

Prostate. 2011 Mar 1;71(4):353-67.

PMID: 20812223

1

Coregulator Recruitment and Histone Modifications in Transcriptional Regulation by the Androgen Receptor

Zhigang Kang, Olli A Jänne, Jorma J Palvimo

Mol Endocrinol. 2004 Nov;18(11):2633-48.

PMID: 15308689

1

MicroRNA Expressions Associated With Progression of Prostate Cancer Cells to Antiandrogen Therapy Resistance

Richard Ottman, Camha Nguyen, Robert Lorch, Ratna Chakrabarti

Mol Cancer. 2014 Jan 3;13:1.

PMID: 24387052

1

The Potential Clinical Benefit of Targeting Androgen Receptor (AR) in Estrogen-Receptor Positive Breast Cancer Cells Treated With Exemestane

Cristina Amaral, Tiago V Augusto, Marta Almada, Sara C Cunha, Georgina Correia-da-Silva, Natércia Teixeira

Biochim Biophys Acta Mol Basis Dis. 2020 May 1;1866(5):165661.

PMID: 31891807

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode